🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial

RecruitingPhase 3Ages 18 Years - anyAllSeoul National University Bundang Hospital
NCT05211375 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this study, the effects of SG with DJB and SG alone for the treatment of type 2 diabetes mellitus (T2DM) will be compared in patients other than the two groups at both extremes who are expected to show excellent effects of metabolic surgery with SG alone (mild T2DM) and who need SG with DJB (severe T2DM). This study is to target patients with poor blood sugar control despite current medical treatment, although the beta-cell function of the pancreas is preserved. Therefore, this study is aimed at patients who have been using insulin for less than 10 years with T2DM, or taking diabetic medications with HbA1c ≥ 7.0% for less than 10 years with T2DM. The investigators hypothesize that the treatment effects of SG with DJB for T2DM will be superior to that of SG in this group

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age over 18 years * BMI equal to or greater than 27.5 kg/m2 * T2DM duration ≤ 10 years * Using insulin, or HbA1c ≥ 7.0% while taking diabetes medication * C-peptide level higher than 1.0 ng/mL * Presence of type 2 diabetes fulfilling the following criteria * Consent to not become pregnant for at least 1 year after surgery * Willingness to provide voluntary informed consent Exclusion Criteria: * Presence of uncontrolled severe gastroesophageal reflux (LA classification C or more in esophagogastroduodenoscopy) * History of previous metabolic surgery for T2DM * History of gastrointestinal surgery, such as gastrectomy or anti-reflux surgery, which may affect the result of metabolic surgery * Therapy regimen of more than 3 psychiatric drugs owing to poorly controlled psychiatric disorders * Suicidal attempts within the last 12 months * Treatment for alcohol and drug abuse within the last 12 months * Vulnerability factors (lacking mental capacity, pregnancy or planning of pregnancy, lactation) * Unsuitability as per the discretion of the researcher
💊

What it tests

  • Duodenojejunal bypass
  • Sleeve gastrectomy
📍

Where

1 site
Seoul National University Bundang Hospital
Seongnam-si, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy